Andrew Fire

Andrew Fire
Born	Andrew Zachary Fire 4/27/1959
Birthplace	Palo Alto, California, U.S.
Nationality	American
Occupation	Biologist, professor
Title	Professor of Pathology and of Genetics
Employer	Stanford University School of Medicine
Known for	RNA interference (RNAi)
Education	University of California, Berkeley (B.A.) Massachusetts Institute of Technology (Ph.D.)
Awards	Nobel Prize in Physiology or Medicine (2006)

Andrew Zachary Fire (born April 27, 1959) is an American biologist and professor of pathology and genetics at the Stanford University School of Medicine. He grew up in Palo Alto, California, the very place where Stanford sits. In 2006, he won the Nobel Prize in Physiology or Medicine, sharing it with Craig C. Mello, for discovering RNA interference (RNAi), a fundamental mechanism that allows cells to silence gene expression. They conducted their landmark research at the Carnegie Institution of Washington and published it in 1998 in Nature, showing that double-stranded RNA could turn off specific genes in the nematode Caenorhabditis elegans.

That discovery changed everything. It opened entirely new ways to understand how genes are controlled and transformed how researchers approach biomedical questions. Scientists could now study disease-causing genes, and the mechanism offered hope for treatments ranging from viral infections to cancer. Fire spent most of his career exploring how genes turn on and off, first at Johns Hopkins University, then at Stanford, where he's continued pushing the field forward.

Early Life

Andrew Zachary Fire was born on April 27, 1959, in Palo Alto, California. He arrived at the geographic heart of what would become Silicon Valley, steps away from Stanford University, the institution he'd one day call home. A Stanford Report article from his Nobel announcement had a bit of fun with this fact: "Andrew Fire took his first look around at Stanford and started screaming." Just a newborn's cry, really, but the humor wasn't lost.

From an early age, Fire was fascinated by science and learning. In 2025, he donated a library card from the 1970s to the Nobel Prize Museum in Stockholm, Sweden. That worn card speaks volumes about who he was as a young person. It shows his commitment to reading and self-directed study during his formative years.

Growing up in the San Francisco Bay Area meant access to intellectual energy and scientific culture from the start. That environment shaped him deeply. Fire believed then, as he does now, that curiosity and access to knowledge matter profoundly for young scientists.

Education

Fire studied mathematics at the University of California, Berkeley, earning his Bachelor of Arts degree there. He moved on to graduate work at the Massachusetts Institute of Technology (MIT), one of the world's premier research institutions. Under the supervision of Phillip Allen Sharp, a molecular biologist who'd win the Nobel Prize himself in 1993 for discovering gene splicing, Fire dug into doctoral research. He finished his Ph.D. in 1983. His dissertation was titled "In vitro transcription studies of adenovirus." That work focused on transcription, the process where DNA's genetic code gets copied into RNA. It gave him the strong foundation in molecular biology he'd need later.

After his doctorate came postdoctoral research at the MRC Laboratory of Molecular Biology in Cambridge, England. That lab had produced numerous Nobel laureates. It was there Fire developed his passion for working with Caenorhabditis elegans, a small nematode worm that's been crucial to countless biological breakthroughs.

Career

Carnegie Institution and Johns Hopkins University

Fire joined the Carnegie Institution of Washington's Department of Embryology in Baltimore, Maryland, after completing his postdoctoral work in Cambridge. At Carnegie, he built his own research program focused on gene expression and gene control in C. elegans. The nematode's simple body, fully sequenced genome, and well-studied development made it perfect for investigating the molecular switches that turn genes on and off.

While there, he also held an adjunct position at Johns Hopkins University, embedding himself firmly in Baltimore's thriving biomedical research scene. Carnegie Institution. That's where the work happened that would eventually earn him the Nobel Prize.

Discovery of RNA Interference

Fire made his most famous discovery while collaborating with Craig C. Mello from the University of Massachusetts Medical School. Their paper, "Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans," appeared in Nature on February 19, 1998.

Here's what they found: double-stranded RNA (dsRNA), where two complementary strands pair up together, could silence specific genes with extraordinary power and precision. Before this work, scientists knew that injecting single-stranded RNA into C. elegans produced small effects on genes. But Fire and Mello noticed something striking. When they injected double-stranded RNA matching a particular gene, the silencing was far more dramatic than either strand alone could cause.

The Nobel Committee called it "a fundamental mechanism for controlling the flow of genetic information." The double-stranded RNA triggered a cellular process that destroyed the matching messenger RNA (mRNA), stopping that gene from making protein. Better still, it was highly specific, targeting only the gene matching the dsRNA sequence. It worked efficiently too. You needed only small amounts of dsRNA to get powerful results.

The discovery's implications rippled outward immediately. RNAi wasn't just something in nematodes. It existed across organisms, from plants to insects to mammals. Here was an ancient cellular defense mechanism, probably evolved to fight viruses and control transposons, which are mobile genetic elements. RNAi also gave researchers a revolutionary tool. By designing specific dsRNA molecules, scientists could now silence virtually any gene and watch what happened, revealing that gene's actual role in living systems.

The pharmaceutical and biotech industries took notice fast. If you could silence disease genes, you might treat viral infections, heart disease, cancer, and genetic disorders. The potential was enormous. The Nobel Committee noted that RNAi was "already being widely used in basic science as a method to study the function of genes" and would "likely lead to novel medical applications in the future."

Stanford University

In 2003, Fire left Carnegie Institution for Stanford University School of Medicine, where he became Professor of Pathology and of Genetics. He went back to the Palo Alto area where he'd been born. His career had come full circle.

Fire's lab at Stanford investigates questions about gene expression, RNA biology, and how organisms respond to foreign or unusual nucleic acids. His work continues exploring what small RNA molecules do and how cells detect and react to double-stranded RNA. He still uses C. elegans as his main experimental system but also works with other organisms.

His position placed him within Stanford's distinguished community of molecular biologists and geneticists. The university's School of Medicine provided the support and resources he needed to keep advancing the field. His presence also shaped many graduate students and postdoctoral researchers who passed through his laboratory.

Continued Research and Public Engagement

Fire's work extends beyond the lab bench. In 2006, he and Mello did an interview with Adam Smith for the Nobel Foundation, discussing how they made their discovery, how they worked together, and what RNAi means for biology and medicine.

He's committed to scientific literacy and intellectual curiosity. That 1970s library card he donated to the Nobel Prize Museum in Stockholm in 2025 reflects this deeply. The museum recognized it as a meaningful symbol of how knowledge access and self-directed reading shape scientists from an early age. Fire believes the real foundations of scientific achievement are built long before you enter a research lab.

Recognition

Nobel Prize in Physiology or Medicine

On October 2, 2006, Karolinska Institutet announced that Andrew Z. Fire and Craig C. Mello had won the Nobel Prize in Physiology or Medicine "for their discovery of RNA interference – gene silencing by double-stranded RNA." Their 1998 Nature paper was recognized as a landmark contribution to understanding gene regulation. The Nobel Committee described RNAi as "a fundamental mechanism for controlling the flow of genetic information" and said it had "already opened up new possibilities in medicine."

The speed was remarkable. Only eight years separated publication from the prize. That's how fast RNAi's impact on biological research became obvious. According to the Nobel Committee's popular information document, the discovery "clarified many previously unexplained observations and revealed a natural mechanism for controlling the flow of genetic information."

Fire split the prize equally with Mello. He was 47 and already at Stanford. The Stanford Report made much of his Palo Alto roots and the arc of his career, from birth in the area to his appointment at the School of Medicine.

Other Honors

Fire's received many other honors throughout his career, recognizing his work in molecular biology and genetics. Britannica lists him among the notable American scientists of his generation. His work has influenced multiple areas of biological and medical research. That influence keeps growing as more scientists build on what he discovered.

Legacy

The discovery of RNA interference by Fire and Mello transformed the biological sciences and medicine forever. RNAi gave researchers an unprecedented tool for studying how genes work. Scientists could now silence individual genes and see what happened, what went wrong. That became essential in genetics, developmental biology, and countless other fields. The technique accelerated genetic research and helped scientists figure out what thousands of genes actually do across many species.

In medicine, RNAi's principles moved into real treatments. Using small interfering RNA (siRNA) molecules to silence disease genes opened new frontiers in drug development. Pharmaceutical companies and researchers have pursued RNAi therapies for hereditary diseases, viral infections, and cancers. The first RNAi therapeutic, patisiran, got FDA approval in 2018 for hereditary transthyretin-mediated amyloidosis. That approval validated what Fire and Mello had described in nematodes twenty years earlier.

Fire's contributions go beyond that single discovery. His career shows the value of basic research in model organisms. Work on C. elegans might seem distant from human medicine, but it repeatedly yields insights of fundamental importance to human health. Sydney Brenner established that tradition. Fire continued it. Others do today.

His legacy extends to the scientists he's trained and mentored at Carnegie Institution, Johns Hopkins, and Stanford. His research group advanced our understanding of RNA biology, gene control, and how organisms defend themselves against foreign nucleic acids.

That library card he donated? It represents something larger about Fire's legacy. It's a reminder that scientific achievement often starts with curiosity, reading, and the hunger to learn.